DE69220382D1 - Verwendung von Peptidderivaten - Google Patents
Verwendung von PeptidderivatenInfo
- Publication number
- DE69220382D1 DE69220382D1 DE69220382T DE69220382T DE69220382D1 DE 69220382 D1 DE69220382 D1 DE 69220382D1 DE 69220382 T DE69220382 T DE 69220382T DE 69220382 T DE69220382 T DE 69220382T DE 69220382 D1 DE69220382 D1 DE 69220382D1
- Authority
- DE
- Germany
- Prior art keywords
- peptide derivatives
- peptide
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F289/00—Macromolecular compounds obtained by polymerising monomers on to macromolecular compounds not provided for in groups C08F251/00 - C08F287/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4086091 | 1991-02-14 | ||
JP29748291 | 1991-11-13 | ||
JP4022799A JP2745351B2 (ja) | 1991-02-14 | 1992-02-07 | ペプチド誘導体及びその用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69220382D1 true DE69220382D1 (de) | 1997-07-17 |
DE69220382T2 DE69220382T2 (de) | 1997-09-18 |
Family
ID=27283972
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69223266T Expired - Fee Related DE69223266T2 (de) | 1991-02-14 | 1992-02-13 | Peptidderivate und deren Verwendung |
DE69220382T Expired - Fee Related DE69220382T2 (de) | 1991-02-14 | 1992-02-13 | Verwendung von Peptidderivaten |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69223266T Expired - Fee Related DE69223266T2 (de) | 1991-02-14 | 1992-02-13 | Peptidderivate und deren Verwendung |
Country Status (4)
Country | Link |
---|---|
US (1) | US5436221A (de) |
EP (2) | EP0503301B1 (de) |
JP (1) | JP2745351B2 (de) |
DE (2) | DE69223266T2 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU626815B2 (en) * | 1987-09-28 | 1992-08-13 | La Jolla Cancer Research Foundation | Selection for cells having increased cell adhesion properties |
US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
AU696206B2 (en) * | 1992-10-02 | 1998-09-03 | Cis Bio International | Multimeric polyvalent antithrombotic agents |
US5981478A (en) * | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
US6492332B1 (en) * | 1995-12-12 | 2002-12-10 | Omeros Corporation | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation |
US6037324A (en) * | 1996-01-04 | 2000-03-14 | Leukosite, Inc. | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor |
US5840514A (en) * | 1996-11-21 | 1998-11-24 | The Regents Of The University Of Michigan | Methods of testing cancer and anticancer drugs |
US6001965A (en) | 1996-11-21 | 1999-12-14 | The Regents Of The University Of Michigan | Anticancer compounds and methods |
AU2003271173A1 (en) * | 2002-10-11 | 2004-05-04 | Chugai Seiyaku Kabushiki Kaisha | Cell growth regulator |
WO2005077382A1 (ja) * | 2004-02-17 | 2005-08-25 | National Institute Of Advanced Industrial Science And Technology | プリオン増殖抑制剤 |
US20060078535A1 (en) * | 2004-10-13 | 2006-04-13 | The Regents Of The University Of Michigan | Anticancer compounds and methods |
US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
EP2064228B1 (de) | 2006-11-10 | 2012-08-29 | Cara Therapeutics, Inc. | Synthetische peptidamide |
US8906859B2 (en) | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
RU2486907C2 (ru) * | 2006-12-04 | 2013-07-10 | Джонс Хопкинс Юниверсити | Имидированный биополимерный адгезив и гидрогель |
BRPI0813858B1 (pt) * | 2007-07-31 | 2019-09-17 | Glytech, Inc. | Métodos para a produção de um peptídeo e de um glicopeptídeo |
EP2187908A1 (de) * | 2007-09-11 | 2010-05-26 | Mondobiotech Laboratories AG | Verwendung des peptids gly-arg-gly-asp-asn-pro als therapeutisches mittel |
US20100150949A1 (en) * | 2008-12-16 | 2010-06-17 | Oncopharmacologics, Inc. | Methods and compositions for modulating proline levels |
CN104837997A (zh) * | 2012-09-25 | 2015-08-12 | 建新公司 | 用于肌强直性营养不良治疗的肽连接吗啉代反义寡核苷酸 |
JP6460382B2 (ja) * | 2014-11-28 | 2019-01-30 | 株式会社豊田自動織機 | 飽和ヘテロ環含有化合物、並びにこれを用いた二次電池用電極及び二次電池、結着剤、蛍光物質 |
WO2016144905A1 (en) | 2015-03-06 | 2016-09-15 | Stealth Biotherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
IT202000004528A1 (it) * | 2020-03-04 | 2021-09-04 | Carmen Lammi | Peptidi auto-assemblanti |
CN112262936A (zh) * | 2020-10-22 | 2021-01-26 | 珠海麦得发生物科技股份有限公司 | 一种含3-羟基丁酸的饮品及其制备方法和应用 |
CN115010918B (zh) * | 2022-07-21 | 2023-10-13 | 中国科学院长春应用化学研究所 | 一种聚氨基酸及其制备方法、纳米疫苗 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4505853A (en) * | 1983-11-18 | 1985-03-19 | Ortho Pharmaceutical Corporation | Enzyme-resistant immunomodulatory peptides |
FR2591227B1 (fr) * | 1985-12-06 | 1988-11-10 | Pasteur Institut | Peptides capables d'inhiber les interactions entre les virus lav et les lymphocytes t4, produits qui en sont derives et leurs applications |
DE3634084A1 (de) * | 1986-10-07 | 1988-04-21 | Hanse Chemie Gmbh | Modifiziertes reaktionsharz, verfahren zu seiner herstellung und seine verwendung |
AU3418389A (en) * | 1988-03-28 | 1989-10-16 | Regents Of The University Of California, The | Nerve growth factor peptides |
JP2625156B2 (ja) * | 1988-06-24 | 1997-07-02 | 市郎 東 | 細胞接着活性コア配列の繰り返し構造からなるポリペプチド |
KR0176966B1 (ko) * | 1988-11-09 | 1999-04-01 | 제니스 케이. 맥밀리언 | 재조합 방법으로 제조한 기능적 합성 단백질 폴리머 |
US5169836A (en) * | 1988-11-10 | 1992-12-08 | Trustees Of The University Of Penna. | Inhibitors of platelet binding |
US5196510A (en) * | 1988-12-29 | 1993-03-23 | Cytogen Corporation | Molecular recognition units |
DK608589D0 (da) * | 1989-12-01 | 1989-12-01 | Holm Arne | Kemisk fremgangsmaade |
-
1992
- 1992-02-07 JP JP4022799A patent/JP2745351B2/ja not_active Expired - Fee Related
- 1992-02-13 EP EP92102442A patent/EP0503301B1/de not_active Expired - Lifetime
- 1992-02-13 DE DE69223266T patent/DE69223266T2/de not_active Expired - Fee Related
- 1992-02-13 US US07/834,848 patent/US5436221A/en not_active Expired - Fee Related
- 1992-02-13 DE DE69220382T patent/DE69220382T2/de not_active Expired - Fee Related
- 1992-02-13 EP EP94101494A patent/EP0619118B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH05186499A (ja) | 1993-07-27 |
US5436221A (en) | 1995-07-25 |
EP0619118A1 (de) | 1994-10-12 |
DE69223266D1 (de) | 1998-01-08 |
EP0503301B1 (de) | 1997-11-26 |
EP0503301A2 (de) | 1992-09-16 |
DE69223266T2 (de) | 1998-03-19 |
DE69220382T2 (de) | 1997-09-18 |
EP0619118B1 (de) | 1997-06-11 |
JP2745351B2 (ja) | 1998-04-28 |
EP0503301A3 (en) | 1993-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69220382D1 (de) | Verwendung von Peptidderivaten | |
FI941398A0 (fi) | Modifioituja peptidijohdannaisia | |
ATE190066T1 (de) | Neuartige peptidderivate | |
DE69431880D1 (de) | Verwendung von (2-imidazolin-2-yl-amino) quinoxalinderivaten | |
ATA53492A (de) | Verwendung von ciclosporin zur pulmonalen verabreichung | |
FR2639947B1 (fr) | Derives peptidiques | |
DE69232476D1 (de) | Feststellung von Fehlern | |
DE59309479D1 (de) | Verwendung von detergensgemischen | |
DE69434520D1 (de) | Biotinylierung von proteinen | |
DK163689D0 (da) | Peptidderivater | |
NO924395L (no) | Rekombinante menneske-faktor viii derivater | |
DE59209936D1 (de) | Verwendung von Acetalen | |
DK375789A (da) | Peptidderivater | |
DE69628195D1 (de) | Verwendung von xyloglucanendotransglycosylase | |
DK132892D0 (da) | Proteiner | |
DK273089A (da) | Anvendelse af peptidderivater | |
DE69514284D1 (de) | Herstellung von Catechol-Estrogen-Derivaten | |
FI941749A0 (fi) | Rekombinantti-Borrelia -proteiinien valmistus | |
DK301889A (da) | Peptidderivater | |
FI934588A0 (fi) | Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben | |
DE59204051D1 (de) | Verwendung von polymodalem beta-Oktogen. | |
DK177789D0 (da) | Peptidderivater | |
FI942467A0 (fi) | Proteesivakaat proteiinit | |
DK657189A (da) | Peptidderivater | |
DE59308823D1 (de) | Verwendung von Thioalkandionen als Aromastoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |